Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies
- A. Flint, A. Raben, J. Blundell, A. Astrup
- MedicineInternational Journal of Obesity
- 2000
VAS scores are reliable for appetite research and do not seem to be influenced by prior diet standardization, however, consideration should be given to the specific parameters being measured, their sensitivity and study power.
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
The results show that GLP-1 enhanced satiety and reduced energy intake and thus may play a physiological regulatory role in controlling appetite and energy intake in humans.
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
- C. Verdich, A. Flint, A. Astrup
- Medicine, BiologyJournal of Clinical Endocrinology and Metabolism
- 1 September 2001
The aim was to examine the effect of glucagon-like peptide-1 on subsequent energy intake using a data set composed of subject data from previous studies and from two as yet unpublished studies, and investigate whether the effect on energy intake is dose dependent and differs between lean and overweight subjects.
Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake.
- A. Raben, L. Agerholm-Larsen, A. Flint, J. Holst, A. Astrup
- MedicineAmerican Journal of Clinical Nutrition
- 2003
The data do not support the proposed relation between the macronutrient oxidation hierarchy and the satiety hierarchy, and despite differences in substrate metabolism and hormone concentrations, satiety and ad libitum energy intake were not significantly different between meals.
No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.
- B. Sloth, I. Krog-Mikkelsen, A. Raben
- MedicineAmerican Journal of Clinical Nutrition
- 1 August 2004
This study does not support the contention that low-fat LGI diets are more beneficial than HGI diets with regard to appetite or body-weight regulation as evaluated over 10 wk, but it confirms previous findings of a beneficial effect ofLGI diets on risk factors for ischemic heart disease.
Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.
- B. Sloth, J. Holst, A. Flint, N. T. Gregersen, A. Astrup
- Medicine, BiologyAmerican Journal of Physiology. Endocrinology and…
- 1 April 2007
Peptide YY (PYY)(3-36) has been shown to produce dramatic reductions in energy intake (EI), but no human data exist regarding energy expenditure (EE), glucose and fat metabolism. Nothing is known…
Dietary supplement use by varsity athletes at a Canadian university.
- M. Kristiansen, R. Levy-Milne, S. Barr, A. Flint
- EducationInternational Journal of Sport Nutrition…
- 1 April 2005
A need for nutrition education among both varsity athletes and university students is indicated, with many subjects indicated knowing little about supplements and wanting to learn more.
Effect of sensory perception of foods on appetite and food intake: a review of studies on humans
- L. B. Sørensen, P. Møller, A. Flint, M. Martens, A. Raben
- PsychologyInternational Journal of Obesity
- 1 October 2003
Results from studies investigating the link between the sensory perception of food and human appetite regulation are reviewed, finding that increasing the food variety can increase food and energy intake and in the short to medium term alter energy balance.
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
- A. Flint, A. Raben, A. Ersbøll, J. Holst, A. Astrup
- MedicineInternational Journal of Obesity
- 1 June 2001
It is concluded that GLP-1 in physiological concentrations powerfully reduces the rate of entry of nutrients into the circulation by a reduction of gastric emptying rate in obese subjects and may be beneficial in weight reduction.
Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- J. V. van Can, B. Sloth, C. Jensen, A. Flint, E. Blaak, W. Saris
- MedicineInternational Journal of Obesity
- 3 September 2013
Liraglutide-induced weight loss appears to be mediated by reduced appetite and energy intake rather than increased EE, and a relative shift toward increased fat and reduced carbohydrate oxidation was observed with liragLutide.
...
...